Prostate Cancer Diagnostics Market Driven by Growing Geriatric Demographic in Emerging Countries

By , in PR PR Health on .

Brooklyn, NY — 11/16/2017 — QYResearchReports.com announces the addition of a new report on the global prostate cancer diagnostics market. The report presents a thorough review of the historical growth trajectory exhibited by the prostate cancer diagnostics market, comprehensive latest figures illustrating each corner of the growing market, and reliable forecasts regarding the global prostate cancer diagnostics market's valuation in the coming years. The report is titled 'Global Prostate Cancer Diagnostics Market Research Report 2017.'

According to the report, the global prostate cancer diagnostics market was valued at around US$11 bn in 2016. The market has exhibited a healthy growth rate in the ongoing decade due to the steady rise in demand and gradual discovery of new unaddressed patient demographics.

The global prostate cancer diagnostics market is segmented by product type into imaging, biopsy, tumor biomarker tests, and others. A review of the historical figures and present status of each segment is given in the report, providing readers with a granular understanding of the product segmentation of the global prostate cancer diagnostics market. Similar attention is paid to the age segmentation of the global prostate cancer diagnostics market, wherein the report segments the market into 55-75, below 55, and above 75. The current figures of each age segment of the global prostate cancer diagnostics market are also provided. The report also provides forecasts till 2022 for each segment of the global prostate cancer diagnostics market.

Get free sample copy of the report with TOC at: https://www.qyresearchreports.com/sample/sample.php?rep_id=1054514&type=S

As prostate cancer is a primarily age-related condition, the global prostate cancer diagnostics market is likely to benefit significantly from the steady expansion of the geriatric demographic across the world. Improvement in the standard of healthcare has come naturally in developed countries, whereas developing economies with rapidly growing healthcare sectors have followed suit in recent years. The growing disposable income of the geriatric demographic in developing countries has helped drive growth of the prostate cancer diagnostics market and is likely to remain a key driver for the market in the coming years. The steady incorporation of technological advances in the healthcare sector in developed countries has helped the prostate cancer diagnostics market and is likely to be an important driver for the market in the coming years.

The report looks at the prostate cancer diagnostics market's performance in North America, Europe, Japan, and Rest of Asia Pacific. These three regions contain some of the world's largest geriatric demographics and thus are the key regions for the global prostate cancer diagnostics market. The prostate cancer diagnostics market is likely to exhibit steady growth in Asia Pacific countries such as China and India, in addition to Japan, in the coming years, due to the growing private investment in healthcare.

Read Complete Table of Content of the Report at: https://www.qyresearchreports.com/report/global-prostate-cancer-diagnostics-market-research-report-2017.htm/toc

The competitive dynamics of the global prostate cancer diagnostics market are also examined in the report, which profiles the key players operating in the prostate cancer diagnostics market in order to understand the competitive workings of the market. Leading companies examined in the report include Abbott, DiaSorin, Genomic Health, Roche, Siemens Healthcare, Myriad Genetics, MDx Health, OPKO, Ambry Genetics, bioMeriux, and Beckman Coulter.

Table of Contents

1 Prostate Cancer Diagnostics Market Overview1
1.1 Product Overview and Scope of Prostate Cancer Diagnostics1
1.2 Prostate Cancer Diagnostics Segment by Types2
1.2.1 Global Revenue Market Share of Prostate Cancer Diagnostics by Types in 20162
1.2.2 Tumor Biomarker Tests3
1.2.3 Imaging3
1.2.4 Biopsy3
1.2.5 Other4
1.3 Prostate Cancer Diagnostics Segment by Ages5
1.4 Prostate Cancer Diagnostics Market by Regions7
1.4.1 North America Status and Prospect (2012-2022)7
1.4.2 Japan Status and Prospect (2012-2022)8
1.4.3 Europe Status and Prospect (2012-2022)8
1.4.4 Asia (Ex. Japan) Status and Prospect (2012-2022)9
1.4.5 Other Status and Prospect (2012-2022)9
1.5 Global Market Size (Value) of Prostate Cancer Diagnostics (2012-2022)10

2 Global Prostate Cancer Diagnostics Market Competition by Manufacturers11
2.1 Global Prostate Cancer Diagnostics Revenue and Share by Manufacturers (2016 and 2017)11
2.2 Global Prostate Cancer Diagnostics Gross and Share by Manufacturers (2016 and 2017)13
2.3 Global Prostate Cancer Diagnostics Average Gross Margin by Manufacturers (2016 and 2017)16
2.4 Manufacturers Prostate Cancer Diagnostics Headquarters and Established Date18
2.5 Prostate Cancer Diagnostics Market Competitive Situation and Trends20
2.5.1 Prostate Cancer Diagnostics Market Concentration Rate20
2.5.2 Prostate Cancer Diagnostics Market Share of Top 3 and Top 5 Manufacturers21
2.5.3 Mergers & Acquisitions, Expansion22

3 Global Prostate Cancer Diagnostics Gross, Revenue (Value) by Regions (2012-2017)23
3.1 Global Prostate Cancer Diagnostics Revenue (Value) and Market Share by Regions (2012-2017)23
3.2 Global Prostate Cancer Diagnostics Gross and Market Share by Regions (2012-2017)25
3.3 Global Prostate Cancer Diagnostics Revenue, Gross and Gross Margin (2012-2017)27
3.4 North America Prostate Cancer Diagnostics Revenue, Gross and Gross Margin (2012-2017)27
3.5 Europe Prostate Cancer Diagnostics Revenue, Gross and Gross Margin (2012-2017)27
3.6 Japan Prostate Cancer Diagnostics Revenue, Gross and Gross Margin (2012-2017)28
3.7 Asia (Ex. Japan) Prostate Cancer Diagnostics Revenue, Gross and Gross Margin (2012-2017)28
3.8 Other Prostate Cancer Diagnostics Revenue, Gross and Gross Margin (2012-2017)28

4 Global Prostate Cancer Diagnostics Supply, Consumption Value, Export, Import by Regions (2012-2017)29
4.1 Global Prostate Cancer Diagnostics Consumption Value by Regions (2012-2017)29
4.2 North America Prostate Cancer Diagnostics Supply, Consumption Value, Export, Import by Regions (2012-2017)31
4.3 Europe Prostate Cancer Diagnostics Supply, Consumption Value, Export, Import by Regions (2012-2017)31
4.4 Japan Prostate Cancer Diagnostics Supply, Consumption Value, Export, Import by Regions (2012-2017)32
4.5 Asia (Ex. Japan) Prostate Cancer Diagnostics Supply, Consumption Value, Export, Import by Regions (2012-2017)32

5 Global Prostate Cancer Diagnostics Gross, Revenue (Value), Gross Margin Trend by Types33
5.1 Global Prostate Cancer Diagnostics Revenue and Market Share by Types (2012-2017)33
5.2 Global Prostate Cancer Diagnostics Gross and Market Share by Types (2012-2017)35
5.3 Global Prostate Cancer Diagnostics Gross Margin by Type (2012-2017)36
5.4 Global Prostate Cancer Diagnostics Gross Growth by Type (2012-2017)37

About QYReseachReports.com
QYReseachReports.com delivers the latest strategic market intelligence to build a successful business footprint in China. Our syndicated and customized research reports provide companies with vital background information of the market and in-depth analysis on the Chinese trade and investment framework, which directly affects their business operations. Reports from QYReseachReports.com feature valuable recommendations on how to navigate in the extremely unpredictable yet highly attractive Chinese market.

Contact US:
Brooklyn, NY 11230
United States
Toll Free: 866-997-4948 (USA-CANADA)
Tel: +1-518-618-1030
Web: http://www.qyresearchreports.com
Email: [email protected]

The following two tabs change content below.
Brad Bennett

Brad Bennett

Brad grew up in a small town in northern Iowa. He studied chemistry in college, graduated, and married his wife one month later. They were then blessed with two baby boys within the first four years of marriage. Having babies gave their family a desire to return to the old paths – to nourish their family with traditional, homegrown foods; rid their home of toxic chemicals and petroleum products; and give their boys a chance to know a simple, sustainable way of life. They are currently building a homestead from scratch on two little acres in central Texas. There’s a lot to be done to become somewhat self-sufficient, but they are debt-free and get to spend their days living this simple, good life together with their five young children.
%d bloggers like this: